Nakajima M, Yokoi T, Mizutani M, Kinoshita M, Funayama M, Kamataki T
Laboratory of Drug Metabolism, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido, 060-0812, Japan.
J Biochem. 1999 Apr;125(4):803-8. doi: 10.1093/oxfordjournals.jbchem.a022352.
A genetic polymorphism was identified in the 5'-flanking region of human CYP1A2 gene, and its effect on the transcriptional activation of the CYP1A2 gene was investigated. Nucleotide sequence analysis revealed the existence of a point mutation from guanine (wild type) to adenine (mutated type) at position -2964 in the gene. This point mutation was detected by a polymerase chain reaction-restriction fragment length polymorphism method using DdeI or BslI restriction enzyme, and was proven to be genetically inherited. Allele frequency in 116 Japanese subjects showed 0.77 and 0.23 for the wild and mutated types of allele, respectively. The point mutation caused a significant decrease of CYP1A2 activity measured by the rate of caffeine 3-demethylation in Japanese smokers (p<0.05). Gel retardation analysis showed the existence of protein bound to the polymorphic locus. These results suggest that this polymorphism is a causal factor of decreased CYP1A2 inducibility.
在人类CYP1A2基因的5'-侧翼区域鉴定出一种基因多态性,并研究了其对CYP1A2基因转录激活的影响。核苷酸序列分析显示该基因中-2964位存在从鸟嘌呤(野生型)到腺嘌呤(突变型)的点突变。该点突变通过使用DdeI或BslI限制性内切酶的聚合酶链反应-限制性片段长度多态性方法检测到,并被证明是可遗传的。116名日本受试者的等位基因频率显示,野生型和突变型等位基因分别为0.77和0.23。该点突变导致日本吸烟者中通过咖啡因3-去甲基化速率测量的CYP1A2活性显著降低(p<0.05)。凝胶阻滞分析显示存在与多态性位点结合的蛋白质。这些结果表明这种多态性是CYP1A2诱导性降低的一个因果因素。